{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:43:59Z","timestamp":1781768639617,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL153407"],"award-info":[{"award-number":["HL153407"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.amjcard.2021.07.044","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T23:17:59Z","timestamp":1630192679000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Prognosticators of All-Cause Mortality in Patients With Heart Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"158","author":[{"given":"Jack B.","family":"Lopuszynski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia J.","family":"Downing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Finley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliha","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2021.07.044_bib0001","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0002","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0003","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1874192401610010158","article-title":"Impaired myocardial bioenergetics in HFpEF and the role of antioxidants","volume":"10","author":"Hiebert","year":"2016","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0004","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0005","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1253\/circrep.CR-20-0051","article-title":"Factors associated with elevated N-terminal pro B-type natriuretic peptide concentrations at the convalescent stage and 1-year outcomes in patients with heart failure with preserved ejection fraction","volume":"2","author":"Oeun","year":"2020","journal-title":"Circ Rep"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0006","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3892\/etm.2021.9874","article-title":"Serum NT-proBNP and TUG1 as novel biomarkers for elderly hypertensive patients with heart failure with preserved ejection fraction","volume":"21","author":"Zhang","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0007","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/02813432.2019.1684029","article-title":"Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: a report from the swedish heart failure register","volume":"37","author":"Eriksson","year":"2019","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0008","first-page":"1","article-title":"Heart failure with preserved ejection fraction in Belgium: characteristics and outcome of a real-life cohort","author":"Lejeune","year":"2020","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12877-018-0807-2","article-title":"Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients","volume":"18","author":"Pacho","year":"2018","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0010","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1536\/ihj.20-321","article-title":"Sex differences in clinical characteristics and 2-year prognosis of patients with heart failure grouped by left ventricular ejection fraction status","volume":"61","author":"Wang","year":"2020","journal-title":"Int Heart J"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0011","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1089\/jwh.2018.7404","article-title":"Sex differences in long-term clinical outcomes in patients hospitalized for acute heart failure: a report from the Korean heart failure registry","volume":"28","author":"Chung","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0012","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jamainternmed.2017.7023","article-title":"Blood pressure trajectories in the 20 years before death","volume":"178","author":"Delgado","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0013","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00380-021-01788-0","article-title":"Prognostic significance of diastolic blood pressure in patients with heart failure with preserved ejection fraction","volume":"36","author":"Fuchida","year":"2021","journal-title":"Heart Vessels"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0014","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/ehf2.13251","article-title":"Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score","volume":"8","author":"Huttin","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/ehjci\/jeaa013","article-title":"Prognostic power of left atrial strain in patients with acute heart failure","volume":"22","author":"Park","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0016","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/ehf2.13247","article-title":"Comparison of left ventricular longitudinal systolic function parameters in the prediction of adverse outcome in heart failure with preserved ejection fraction","volume":"8","author":"Gozdzik","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0017","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/ehf2.12754","article-title":"The ventilatory abnormalities and prognostic values of H2 FPEF score in dyspnoeic patients with preserved left ventricle systolic function","volume":"7","author":"Huang","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0018","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.120.045810","article-title":"Proteomic evaluation of the comorbidity-inflammation paradigm in heart failure with preserved ejection fraction: results from the PROMIS-HFpEF study","volume":"142","author":"Sanders-van Wijk","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jjcc.2017.04.006","article-title":"Timing on echocardiography and blood laboratory test is important for future outcome association in hospitalized heart failure patients","volume":"71","author":"Yang","year":"2018","journal-title":"J Cardiol"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0020","first-page":"68","article-title":"Association of visit-to-visit variability in kidney function and serum electrolyte indexes with risk of adverse clinical outcomes among patients with heart failure with preserved ejection fraction","volume":"6","author":"Segar","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0021","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s00392-020-01639-4","article-title":"Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction","volume":"109","author":"Kobayashi","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0022","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/imj.14836","article-title":"Prognostic impact of hyponatremia and hypernatremia at admission and discharge in heart failure patients with preserved, mid-range, and reduced ejection fraction","volume":"51","author":"Vicent","year":"2020","journal-title":"Intern Med J"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0023","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.amjcard.2019.11.006","article-title":"Effect of serum albumin levels in patients with heart failure with preserved ejection fraction (from the TOPCAT trial)","volume":"125","author":"Prenner","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014716","article-title":"Serum albumin Is a marker of myocardial fibrosis, adverse pulsatile aortic hemodynamics, and prognosis in heart failure with preserved ejection fraction","volume":"9","author":"Prenner","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0025","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/ggi.13770","article-title":"Which factors are associated with length of stay in older patients with acute decompensated heart failure with preserved ejection fraction?: AURORA study","volume":"19","author":"Nishino","year":"2019","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0026","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ehf2.12222","article-title":"Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction","volume":"5","author":"Yoshihisa","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0027","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jacc.2019.12.069","article-title":"Multiple plasma biomarkers for risk stratification in patients with heart failure and preserved ejection fraction","volume":"75","author":"Chirinos","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0028","doi-asserted-by":"crossref","first-page":"12440","DOI":"10.1038\/s41598-020-69013-y","article-title":"Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction","volume":"10","author":"Miller","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0029","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ehf2.13250","article-title":"Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT","volume":"8","author":"Peters","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2021.07.044_bib0030","article-title":"Heart failure with preserved ejection fraction, atrial fibrillation, and increased NTproBNP levels: An emergent clinical dilemma","author":"Turkoglu","year":"2020","journal-title":"Herz"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914921007335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914921007335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:39:03Z","timestamp":1757572743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914921007335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":30,"alternative-id":["S0002914921007335"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2021.07.044","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognosticators of All-Cause Mortality in Patients With Heart Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2021.07.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}